Efficacy and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors and Platinum-Containing Chemotherapy for Later-Line Advanced Non-Small Cell Lung Cancer: a Retrospective Three-Arm Real-World Study Using Propensity-Score Matching
FRONTIERS IN ONCOLOGY（2024）
Key words
anlotinib,immune checkpoint inhibitors,PD-1/PD-L1,angiogenesis inhibitors,combination therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined